441 related articles for article (PubMed ID: 9171309)
1. Syndrome of inappropriate antidiuresis without involving inappropriate secretion of vasopressin in an elderly woman: effect of intravenous administration of the nonpeptide vasopressin V2 receptor antagonist OPC-31260.
Kamoi K
Nephron; 1997; 76(1):111-5. PubMed ID: 9171309
[TBL] [Abstract][Full Text] [Related]
2. Effects of an oral vasopressin receptor antagonist (OPC-31260) in a dog with syndrome of inappropriate secretion of antidiuretic hormone.
Fleeman LM; Irwin PJ; Phillips PA; West J
Aust Vet J; 2000 Dec; 78(12):825-30. PubMed ID: 11194468
[TBL] [Abstract][Full Text] [Related]
3. A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Wada K; Matsukawa U; Fujimori A; Arai Y; Sudoh K; Sasamata M; Miyata K
Biol Pharm Bull; 2007 Jan; 30(1):91-5. PubMed ID: 17202666
[TBL] [Abstract][Full Text] [Related]
4. BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats.
Kazama I; Hatano R; Michimata M; Suzuki K; Arata T; Suzuki M; Miyama N; Sato A; Satomi S; Ejima Y; Sasaki S; Matsubara M
Kidney Int; 2005 May; 67(5):1855-67. PubMed ID: 15840033
[TBL] [Abstract][Full Text] [Related]
5. [Etiology, diagnostics and therapy of hyponatremias].
Laczi F
Orv Hetil; 2008 Jul; 149(29):1347-54. PubMed ID: 18617466
[TBL] [Abstract][Full Text] [Related]
6. Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Saito T; Ishikawa S; Abe K; Kamoi K; Yamada K; Shimizu K; Saruta T; Yoshida S
J Clin Endocrinol Metab; 1997 Apr; 82(4):1054-7. PubMed ID: 9100572
[TBL] [Abstract][Full Text] [Related]
7. Effect of tolvaptan on hyponatremia in a dog with syndrome of inappropriate secretion of antidiuretic hormone.
Yamamoto H; Kimura K; Horikirizono H; Tamura Y; Kambayashi S; Baba K; Okuda M; Mizuno T; Igase M
J Vet Med Sci; 2023 Oct; 85(10):1047-1051. PubMed ID: 37587049
[TBL] [Abstract][Full Text] [Related]
8. Close association of urinary excretion of aquaporin-2 with appropriate and inappropriate arginine vasopressin-dependent antidiuresis in hyponatremia in elderly subjects.
Ishikawa Se ; Saito T; Fukagawa A; Higashiyama M; Nakamura T; Kusaka I; Nagasaka S; Honda K; Saito T
J Clin Endocrinol Metab; 2001 Apr; 86(4):1665-71. PubMed ID: 11297601
[TBL] [Abstract][Full Text] [Related]
9. Osmoregulation of vasopressin secretion in patients with the syndrome of inappropriate antidiuresis associated with central nervous system disorders.
Kamoi K; Toyama M; Takagi M; Koizumi T; Niishiyama K; Takahashi K; Sasaki H; Muto T
Endocr J; 1999 Apr; 46(2):269-77. PubMed ID: 10460011
[TBL] [Abstract][Full Text] [Related]
10. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis.
Robertson GL
Am J Med; 2006 Jul; 119(7 Suppl 1):S36-42. PubMed ID: 16843083
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats.
Fujisawa G; Ishikawa S; Tsuboi Y; Okada K; Saito T
Kidney Int; 1993 Jul; 44(1):19-23. PubMed ID: 8355461
[TBL] [Abstract][Full Text] [Related]
12. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
Decaux G
J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide in patients with the syndrome of inappropriate antidiuretic hormone secretion and with diabetes insipidus.
Kamoi K; Ebe T; Kobayashi O; Ishida M; Sato F; Arai O; Tamura T; Takagi A; Yamada A; Ishibashi M
J Clin Endocrinol Metab; 1990 May; 70(5):1385-90. PubMed ID: 2139879
[TBL] [Abstract][Full Text] [Related]
14. Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD.
Arecco A; Demontis D; Della Sala L; Musso N; Gay S; Boschetti M; Ferone D; Gatto F
Front Endocrinol (Lausanne); 2023; 14():1309657. PubMed ID: 38288467
[TBL] [Abstract][Full Text] [Related]
15. Use of intravenous conivaptan in neurosurgical patients with hyponatremia from syndrome of inappropriate antidiuretic hormone secretion.
Potts MB; DeGiacomo AF; Deragopian L; Blevins LS
Neurosurgery; 2011 Aug; 69(2):268-73. PubMed ID: 21792136
[TBL] [Abstract][Full Text] [Related]
16. Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: a cross-sectional study.
Mannesse CK; Jansen PA; Van Marum RJ; Sival RC; Kok RM; Haffmans PM; Egberts TC
Maturitas; 2013 Dec; 76(4):357-63. PubMed ID: 24094459
[TBL] [Abstract][Full Text] [Related]
17. Asymptomatic hyponatremia due to inappropriate secretion of antidiuretic hormone as the first sign of a small cell lung cancer in an elderly man.
Kamoi K; Kurokawa I; Kasai H; Mizusawa A; Ebe T; Sasaki H; Matuzuki Y; Seino Y; Takahashi M; Togashi K; Miyamura H; Sato Y; Takato H; Kaneko H
Intern Med; 1998 Nov; 37(11):950-4. PubMed ID: 9868958
[TBL] [Abstract][Full Text] [Related]
18. Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism.
Oelkers W
N Engl J Med; 1989 Aug; 321(8):492-6. PubMed ID: 2548097
[TBL] [Abstract][Full Text] [Related]
19. Hyponatremia and antidiuresis syndrome.
Vantyghem MC; Balavoine AS; Wémeau JL; Douillard C
Ann Endocrinol (Paris); 2011 Dec; 72(6):500-12. PubMed ID: 22119069
[TBL] [Abstract][Full Text] [Related]
20. Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans.
Shimizu K
Kidney Int; 1995 Jul; 48(1):220-6. PubMed ID: 7564082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
